文献速递血液净化与透析

动静脉内瘘并发症:一项系统综述

Complications of the Arteriovenous Fistula: A Systematic Review.
PubMed 文献 · J Am Soc Nephrol · 2016-12-28

该系统综述检索了2000至2014年Medline中前瞻性采集数据且内瘘数≥100的英文研究,共纳入43篇文章(61个队列,n>11374个内瘘),总结内瘘并发症发生率。中位并发症发生率(每1000患者日)为动脉瘤0.04、感染0.11、窃血事件0.05、血栓事件0.24、静脉高压事件0.03;研究偏倚风险高且事件率变异大,无法合并结果。

要点

  • 中位并发症发生率(每1000患者日):动脉瘤0.04、感染0.11、窃血事件0.05、血栓事件0.24、静脉高压事件0.03。
  • 许多研究偏倚风险高、事件率变异大,未能呈现合并结果。
  • 研究多未报告与内瘘并发症相关的变量、患者合并症、血管特征、外科医生经验或护理穿刺技术。

核心结论

  • 内瘘并发症发生率存在显著变异,部分源于研究质量差、研究人群显著异质性和定义不一致。
  • 亟需在未来临床研究中标准化血管通路并发症的方法和定义报告,以更好地为患者和提供者决策提供信息。

研究设计与样本

  • 系统综述,检索Medline 2000至2014年的英文研究,纳入前瞻性采集数据且内瘘数≥100的研究。
  • 筛查2292条引文后,43篇文章符合纳入标准(61个独特队列;n>11374个内瘘)。

主要发现

  • 中位并发症发生率(每1000患者日):动脉瘤0.04(14个独特队列;n=1827个内瘘)。
  • 中位并发症发生率(每1000患者日):感染0.11(16个队列;n>6439个内瘘)。
  • 中位并发症发生率(每1000患者日):窃血事件0.05(15个队列;n>2543个内瘘)。
  • 中位并发症发生率(每1000患者日):血栓事件0.24(26个队列;n=4232个内瘘)。
  • 中位并发症发生率(每1000患者日):静脉高压事件0.03(1个队列;n=350个内瘘)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 许多研究偏倚风险高且事件率变异大,因此无法呈现合并结果。
  • 研究通常未报告与内瘘并发症相关的变量、患者合并症、血管特征、外科医生经验或护理穿刺技术。
  • 并发症发生率存在显著变异,部分源于研究质量差、研究人群显著异质性和定义不一致。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The implementation of patient-centered care requires an individualized approach to hemodialysis vascular access, on the basis of each patient's unique balance of risks and benefits. This systematic review aimed to summarize current literature on fistula risks, including rates of complications, to assist with patient-centered decision making. We searched Medline from 2000 to 2014 for English-language studies with prospectively captured data on ≥100 fistulas. We assessed study quality and extracted data on study design, patient characteristics, and outcomes. After screening 2292 citations, 43 articles met our inclusion criteria (61 unique cohorts; n>11,374 fistulas). Median complication rates per 1000 patient days were as follows: 0.04 aneurysms (14 unique cohorts; n=1827 fistulas), 0.11 infections (16 cohorts; n>6439 fistulas), 0.05 steal events (15 cohorts; n>2543 fistulas), 0.24 thrombotic events (26 cohorts; n=4232 fistulas), and 0.03 venous hypertensive events (1 cohort; n=350 fistulas). Risk of bias was high in many studies and event rates were variable, thus we could not present pooled results. Studies generally did not report variables associated with fistula complications, patient comorbidities, vessel characteristics, surgeon experience, or nursing cannulation skill. Overall, we found marked variability in complication rates, partly due to poor quality studies, significant heterogeneity of study populations, and inconsistent definitions. There is an urgent need to standardize reporting of methods and definitions of vascular access complications in future clinical studies to better inform patient and provider decision making.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Al-Jaishi AA, Liu AR, Lok CE, et al. Complications of the Arteriovenous Fistula: A Systematic Review. J Am Soc Nephrol. 2016. PMID: 28031406. doi:10.1681/ASN.2016040412

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。